EXACT SCIENCES CORP Equity Securities without Readily Determinable Fair Value, Downward Price Adjustment, Cumulative Amount
EXACT SCIENCES CORP had Equity Securities without Readily Determinable Fair Value, Downward Price Adjustment, Cumulative Amount of $16.85 million as of 2025-12-31, per its 10-K filed 2026-02-13.
Financial Statements › Notes › Debt and Equity Securities › Equity Securities without Readily Determinable Fair Value, Impairment Loss, Cumulative Amount
us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount · last filed 2026-02-13
- 2025-12-31: Equity Securities without Readily Determinable Fair Value, Downward Price Adjustment, Cumulative Amount $16.85M.
- 2025-09-30: Equity Securities without Readily Determinable Fair Value, Downward Price Adjustment, Cumulative Amount $16.85M.
- 2025-06-30: Equity Securities without Readily Determinable Fair Value, Downward Price Adjustment, Cumulative Amount $16.85M.
- 2025-03-31: Equity Securities without Readily Determinable Fair Value, Downward Price Adjustment, Cumulative Amount $16.85M.
| Period end | Equity Securities without Readily Determinable Fair Value, Downward Price Adjustment, Cumulative Amount | Equity Securities without Readily Determinable Fair Value, Downward Price Adjustment, Cumulative Amount as first filed |
|---|---|---|
| 2025-12-31 | $16.85M 10-K · filed 2026-02-13 | |
| 2025-09-30 | $16.85M 10-Q · filed 2025-11-03 | |
| 2025-06-30 | $16.85M 10-Q · filed 2025-08-06 | |
| 2025-03-31 | $16.85M 10-Q · filed 2025-05-01 | |
| 2024-12-31 | $16.85M 10-K · filed 2026-02-13 | |
| 2024-09-30 | $15.07M 10-Q · filed 2025-11-03 | |
| 2024-06-30 | $15.07M 10-Q · filed 2025-08-06 | |
| 2024-03-31 | $15.10M 10-Q · filed 2025-05-01 | |
| 2023-12-31 | $15.07M 10-K · filed 2025-02-19 | $15.10M 10-K · filed 2024-02-21 |
| 2023-09-30 | $15.07M 10-Q · filed 2024-11-05 | |
| 2023-06-30 | $12.53M 10-Q · filed 2024-07-31 | |
| 2023-03-31 | $11.23M 10-Q · filed 2024-05-08 |